Pharmaceuticals

TMA Pushing To Delay PMP Mandate, Buy Time for Integration With EHRs - 04/09/2019

Starting Sept. 1, physicians will be required to check the PMP before issuing any prescription for opioids, barbiturates, benzodiazepines, or carisoprodol, a mandate the Texas Legislature passed during the 2017 session. As this year’s session of the legislature enters its back stretch, TMA is hoping to persuade lawmakers to delay that mandate until March 2020 to allow for a widespread rollout of PMP-EHR integration.


Google Your Way To Disposing Of Unused Drugs? - 03/21/2019

If you’re looking for a way to help your patients put a dent in the nation’s opioid epidemic, look no further than Google Maps.  Google Maps recently added a search feature that will make it easier for your patients to dispose of unwanted and unused medications.  


Keep Your Patients and Practice Safe from Opioid Prescription Fraud - 03/19/2019

If you prescribe opioids, it’s important to protect your practice and your patients from fraud and substance-use disorder. One way to ensure that patients accurately follow your prescription is to have them sign an informed consent and opioid treatment agreement.


Pharmacy Board Nixes Proposal That Could’ve Broadened Pharmacists’ Scope - 03/14/2019

Medicine’s objections were strong, and the state’s draft rules allowing pharmacists to perform medication therapy management services aren’t going to make it after all.


New Prescription Forms Taking More Than Eight Weeks To Deliver, State Says - 03/11/2019

Update March 11: New official prescription forms for certain controlled substances could take longer than two months to receive, state health officials say.  


Bypassing the Middle Man: Should Texas Allow Physician Dispensing? - 02/11/2019

The Texas Medical Association supports allowing physicians to dispense out of their offices, and TMA and the Texas Academy of Family Physicians (TAFP) are supporting business groups and other leaders as they mount a legislative effort to bring the practice to Texas. Proponents are wielding data that illustrates potential benefits like reduced medication costs and increased patient adherence to their drug regimens.


TMA Weighs In on Opioid-Antagonist Prescriptions - 02/11/2019

The Texas Medical Association continues to track key regulatory changes that could affect your practice, and recently submitted comments on the Texas Medical Board’s proposed rule for the use of opioid antagonists.


Is the PMP Working for You? - 01/16/2019

The Texas Medical Association, in collaboration with the Center for Health Communication at The University of Texas at Austin, invites you to share your expertise on using the Prescription Monitoring Program to help care for your patients.


New Prescription Forms Taking Months to Deliver - 12/20/2018

If you haven’t already ordered new prescription forms for certain controlled substances, you should do so soon in order to stay compliant with new state regulations that will take effect next year. Because of the volume of orders, the new forms are currently taking about two months to be delivered.


Cannabidiol Takes a Big Step Toward Respectability - 11/29/2018

In September, the DEA issued an order listing all drugs approved by the U.S. Food and Drug Administration that contain cannabidiol but no more than 0.1 percent of the chief psychoactive agent in cannabis as Schedule V drugs — those with the least potential for abuse. So far, Epidiolex is the only medication that fits that description.


New Prescription Form Requirements Delayed - 11/26/2018

The Texas State Board of Pharmacy has pushed back the date for when new prescription forms for certain controlled substances will be required.


Too Big a Step? Medicine Urges CMS to Reverse New Step Therapy Policy - 11/02/2018

Medicine urges CMS to reverse new policy allowing “fail-first” drug programs known as step therapy.


Are You Ready for Changes to Opioid Prescribing in Texas? - 10/30/2018

Beginning Sept. 1, all prescribers will be required to set up an account with the state’s prescription monitoring program, known as PMP Aware. The Texas State Board of Pharmacy will also begin issuing new official prescription forms that include advanced security features designed to help deter fraud.


New FDA-Approved Flu Drug Has Roots in Texas - 10/25/2018

The science behind what makes a new flu drug work has roots right here in Texas, particularly The University of Texas at Austin (UT).


Texas Gets $46 Million to Fight Opioid Abuse - 10/12/2018

The Substance Abuse and Mental Health Services Administration recently awarded the Texas Health and Human Services Commission $46.2 million to expand treatment options and to increase access to medication-assisted treatment.


Update: Glitches With State's Schedule II Prescription Forms Fixed - 09/21/2018

Some physicians have not been able to order new prescription forms for certain controlled substances because of problems with the state’s IT system, and the texas.gov website.


Avoid Prescription Denials: Enroll in Medicaid Soon - 07/19/2018

Enroll in Medicaid by July 27 of this year to ensure your Medicaid pharmacy prescriptions get filled.


Your Video Guide to Texas' New Prescription Drug Monitoring Program - 07/10/2018

In an effort to address the very real and debilitating crisis caused by the misuse of  pain medicines, the Texas Legislature has passed legislation to mandate that all prescribers and pharmacists check the state's Prescription Drug Monitoring Program (PDMP) before prescribing or dispensing certain medications.


FDA Approves Cannabidiol, But Drug Still Faces Hurdles - 07/02/2018

The U.S. Food and Drug Administration this week approved the first medication derived from marijuana, which could be used to treat two rare forms of childhood epilepsy.


Survey Asks, Are You A-OK With Using Texas PMP? - 06/29/2018

The Center for Health Communication has created a survey that asks prescribers and pharmacists for their feedback on the Texas Prescription Monitoring Program.


Report Shows Physician Progress in Opioid Crisis - 06/08/2018

A report released late last month highlights physicians’ leadership in the continued efforts to curb the nationwide opioid-abuse epidemic.


CDC: Tainted Synthetic Cannabinoids Causing Coagulopathy Outbreak - 06/04/2018

A multistate outbreak of coagulopathy, including five deaths, has been linked to illegal, synthetic cannabinoid products that are contaminated with the rodent killer brodifacoum, the Centers for Disease Control and Prevention said in a health advisory.


Following National Trend, Texas’ Opioid Prescriptions Drop - 05/04/2018

In a sign that efforts to curb prescription-drug abuse are taking hold, the number of opioid prescriptions written in Texas and nationwide has fallen significantly since 2013, a study released last month shows.


FDA OKs Menactra for Children - 04/26/2018

The U.S. Food and Drug Administration (FDA) has approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.


Is Cannabis Oil Overhyped in Texas? - 04/24/2018

Last week, a young child somewhere in Texas became the first person in the state to fill the state's most unusual prescription – a small container of cannabis oil.